Application of immunotherapy in brain cancer treatment

HIGHLIGHTS

• What: This study showed that rindopepimut was associated with a rise in OS of more than two months, and that anti-EGFRvIII titers were directly connected to survival .
• Who: Ziqi Wang from the Shanghai World Foreign Language Academy, Shanghai, China have published the article: Application of Immunotherapy in Brain Cancer Treatment, in the : Proceedings of ICBioMed 2024 Workshop: Computational Proteomics in Drug Discovery and Development from Medicinal Plants of /2024/
• How: The result showed that the combination therpay can increase the OS rate rise to 80% from 75% which is the OS rate . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.